Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of crohn's disease in Southern Italy

American Journal of Gastroenterology

Volumn 100, Issue 12, 2005, Pages 2730-2736

  Fries, Walter ^a   Renda, Maria C ^b   Lo Presti, Maria A ^a   Raso, Antonella ^a   Orlando, Ambrogio ^b   Oliva, Lorenzo ^b   Giofré, Maria R ^a   Maggio, Aurelio ^b   Mattaliano, Anna ^c   MacAluso, Alfredo ^b   Cottone, Mario ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c AUSL di Casteltermini (Agrigento)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; LACTULOSE; MANNITOL; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; IMMUNE RESPONSE; INCIDENCE; INTESTINE MUCOSA PERMEABILITY; ITALY; PATHOGENESIS; PRIORITY JOURNAL; RELATIVE; ADULT; CAPILLARY PERMEABILITY; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; ENDEMIC DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; INTESTINE MUCOSA; MALE; MIDDLE AGED; MUTATION; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; PEDIGREE; PHYSIOLOGY; POPULATION GENETICS; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT;

ADULT; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; COHORT STUDIES; CROHN DISEASE; ENDEMIC DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INCIDENCE; INTESTINAL MUCOSA; ITALY; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 4;

EID: 33644827003     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00325.x     Document Type: Article

References (44)

1. Bjarnason I MacPherson A Hollander D. Intestinal permeability: An overview. Gastroenterology 1995 108 : 1566 81.
2. Ma TY. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997 214 : 318 27.
3. DeMeo MT Mutlu EA Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002 34 : 385 96.
4. Wyatt J Vogelsang H Hübl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993 341 : 1437 9.
5. Arnott IDR Kingstone K Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 2000 35 : 1163 9.
6. Söderholm JD Olaison G Linberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect of the mucosal defence? Gut 1999 44 : 96 100.
7. Peeters M Geypens B Claus D, et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997 113 : 802 7.
8. Zareie M Paramjit KS Irvine EJ, et al. Monocyte/macrophage activation by normal bacteria and bacterial products. Implications for altered epithelial function in Crohn's disease. Am J Pathol 2001 158 : 1101 9.
9. Mullin JM Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990 50 : 2172 6.
10. Rodriguez P Heyman M Candalh C, et al. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl19A cell monolayers. Cytokine 1995 7 : 441 8.
11. Soderholm JD Streutker C Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 2004 53 : 1817 24.
12. Suenaert P Bulteel V Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002 97 : 2000 4.
13. Zeissig S Bojarski C Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment. Gut 2004 53 : 1295 302.
14. Inoue N Tamura K Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's diesase. Gastroenterology 2002 123 : 86 91.
15. Thjodleifsson B Sigthorsson G Cariglia N, et al. Subclinical intestinal inflammation: An inherited abnormability in Crohn's disease relatives? Gastroenterology 2003 124 : 1728 37.
16. Franchimont D Vermeire S El Housni H, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004 53 : 987 92.
17. Inohara N Ogura Y Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003 278 : 5509 12.
18. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001 1 : 35 45.
19. Arbour NC Lorenz E Schulte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsivness in humans. Nat Genet 2000 25 : 187 91.
20. Rakoff-Nahoum S Paglino J Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229 41.
21. Corcoran A Page I. A method for determination of mannitol in plasma urine. J Biol Chem 1947 170 : 165 71.
22. Behrens RH Doherty H Elia M, et al. A simple enzymatic method for the assay of urinary lactulose. Clin Chim Acta 1984 137 : 361 7.
23. Di Leo V D'Incà R Diaz-Granado N, et al. Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea. Am J Gastroenterol 2003 98 : 2245 52.
24. Scoglio R Di Pasquale G Pagano G, et al. Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol 2003 98 : 1325 31.
25. Hollander D Vadheim CM Brettholz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 1986 105 : 883 5.
26. Teahon K Smethurst P Levi AJ, et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992 33 : 320 3.
27. Howden CW Gillanders I Morris AJ, et al. Intestinal permeability in patients with Crohn's disease and their first-degree relatives. Am J Gastroenterol 1994 89 : 1175 6.
28. Katz KD Hollander D Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989 97 : 927 31.
29. May GR Sutherland LR Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993 104 : 1627 32.
30. Yacyshyn BR Meddings JB. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 1995 108 : 132 7.
31. Klingenberg-Noftz RD. Mucosal blood flow, fecal calprotectin and intestinal permeability are closely related to mucosal inflammation in patients with IBD. Gut 2004 53 ( Suppl VI A218.
32. Menzies IS Zuckerman MJ Nukajam WS, et al. Geography of intestinal permeability and absorption. Gut 1999 44 : 483 9.
33. Breslin NP Nash C Hilsden RJ, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001 96 : 2934 8.
34. Comes MC Gower-Rousseau C Colombel JF, et al. Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liege county of Belgium. Gut 1994 35 : 1316 8.
35. Irvine EJ Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000 119 : 1740 4.
36. Esters N Pierik M van Steen K, et al. Transmission of CARD15 (NOD2) variants in families with Crohn's disease. Am J Gastroenterol 2004 99 : 299 305.
37. Annese V Calmieri O Latiano A, et al. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig Liver Dis 2004 36 : 121 4.
38. Vavassori P Borgiani P Biancone L, et al. CARD15 mutation analysis in an Italian population. Leu1007finsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 2004 10 : 116 21.
39. Abreu MT Taylor KD Lin Y-C, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002 123 : 679 88.
40. Ahmad T Armuzzi A Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002 122 : 854 66.
41. Török H-P Glas J Tonenchi L, et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: Association of a mutation in the toll-like receptor 4 with ulcerative colitis. Clin Immunol 2004 112 : 85 91.
42. Okayama N Fujimura K Suehiro Y, et al. Simple genotype analysis of the Asp299Gly polymorphism of the toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal 2002 16 : 56 8.
43. Nimmo ER Arnott IDR Drummond HE, et al. Mutations of toll-like receptor 4 and CD 14 genes are not associated with susceptibility or disease behaviour in inflammatory bowel disease. Gastroenterology 2003 124 ( Suppl 1 A373.
44. Oostenbrug LE De Jong D Drenth JPH, et al. Lack of association between toll-like receptor 4 haplotype and Asp299Gly polymorphism and susceptibility for inflammatory bowel disease. Gastroenterology 2003 124 ( Suppl 1 A372.